Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?
In a new study, researchers evaluated the impact of the SARS-CoV-2 pandemic on the diagnosis and treatment of classical Hodgkin lymphoma (cHL) patients in Istanbul, Turkey.
Source: news-medical.net